Dr Reddy`s inks licensing pact with Takeda to sell gastrointestinal drug
Enforcement Report - Week of July 10, 2024
07.03.24 Aurigene Pharmaceutical Services Limited, a global contract research, development, and manufacturing services organization (CRDMO), will provide discovery services to biotechnology company Edity Therapeutics Limited (Edity) in cell therapy.
Zydus Lifesciences Limited and Dr. Reddy's Laboratories, a global pharmaceutical company, announced the execution of a licensing agreement to co-market Pertuzumab biosimilar in India. Pertuzumab is a critical treatment for HER2 positive breast cancer patients. The biosimilar has been developed in-house by the research team at the Zydus Research Centre (ZRC).
Dr Reddy`s Generic Midostaurin Receives Approval in US
Haleon sells nicotine replacement unit to Dr. Reddy`s for $633M
Dr. Reddy’s to Acquire Nicotinell and Related Portfolio in Significant Step Towards Building Global Consumer Healthcare Business
Dr. Reddy`s Laboratories Limited CTO -- Unit 6
Dr Reddy's Laboratories Share Price | The parties will enter into a commercial supply agreement pursuant to which Ingenus will supply the product to Dr Reddy’s USA.